249 related articles for article (PubMed ID: 16948644)
1. Development of multiple sclerosis after vaccination against hepatitis B: a study based on human leucocyte antigen haplotypes.
Ozakbas S; Idiman E; Yulug B; Pakoz B; Bahar H; Gulay Z
Tissue Antigens; 2006 Sep; 68(3):235-8. PubMed ID: 16948644
[TBL] [Abstract][Full Text] [Related]
2. Multiple sclerosis and vaccination against hepatitis B: analysis of risk benefit profile.
Tosti ME; Traversa G; Bianco E; Mele A
Ital J Gastroenterol Hepatol; 1999; 31(5):388-91. PubMed ID: 10470598
[TBL] [Abstract][Full Text] [Related]
3. [A severe episode in a patient with recurrent disseminated acute encephalitis due to vaccination against hepatitis B. For or against vaccination?].
Cabrera-Gómez JA; Echazabal-Santana N; García González L; Ramos Cedeño AM; Rodríguez Roque MO; López Hernández O; Cabrera Núñez JA; González De La Nuez J; Téllez L
Rev Neurol; 2002 Feb 16-28; 34(4):358-63. PubMed ID: 12022053
[TBL] [Abstract][Full Text] [Related]
4. The development of rheumatoid arthritis after recombinant hepatitis B vaccination.
Pope JE; Stevens A; Howson W; Bell DA
J Rheumatol; 1998 Sep; 25(9):1687-93. PubMed ID: 9733447
[TBL] [Abstract][Full Text] [Related]
5. Hepatitis B vaccination and the risk of multiple sclerosis.
Ascherio A; Zhang SM; Hernán MA; Olek MJ; Coplan PM; Brodovicz K; Walker AM
N Engl J Med; 2001 Feb; 344(5):327-32. PubMed ID: 11172163
[TBL] [Abstract][Full Text] [Related]
6. Hepatitis B vaccine and risk of relapse after a first childhood episode of CNS inflammatory demyelination.
Mikaeloff Y; Caridade G; Assi S; Tardieu M; Suissa S;
Brain; 2007 Apr; 130(Pt 4):1105-10. PubMed ID: 17276994
[TBL] [Abstract][Full Text] [Related]
7. Antibodies against a class II HLA-peptide complex raised by active immunization of mice with antigen mimicking peptides.
Dam-Tuxen R; Riise E
Scand J Immunol; 2009 Aug; 70(2):93-100. PubMed ID: 19630914
[TBL] [Abstract][Full Text] [Related]
8. [Hepatitis B vaccination. Advocating for a protection principle].
Aron E
Bull Acad Natl Med; 2002; 186(2):361-6; discussion 366-8. PubMed ID: 12145843
[TBL] [Abstract][Full Text] [Related]
9. [Immunogenicity of vaccines against viral hepatitis A and B in the population above 40 years of age -- impact of risk factors].
Chlíbek R; Smetana J; Sindelár R; Cecetková B; Prymula R; Kohl I
Epidemiol Mikrobiol Imunol; 2007 Aug; 56(3):119-28. PubMed ID: 17900060
[TBL] [Abstract][Full Text] [Related]
10. Differences in response to a hepatitis B vaccine booster dose among Alaskan children and adolescents vaccinated during infancy.
Samandari T; Fiore AE; Negus S; Williams JL; Kuhnert W; McMahon BJ; Bell BP
Pediatrics; 2007 Aug; 120(2):e373-81. PubMed ID: 17636112
[TBL] [Abstract][Full Text] [Related]
11. Immunization status of thirty patients with sickle cell disease five years post hepatitis B vaccination. A comparison with normal controls.
Jones-Lecointe A; Swanston WM; Charles WP; Simeon D
West Indian Med J; 2001 Dec; 50(4):317-8. PubMed ID: 11993025
[TBL] [Abstract][Full Text] [Related]
12. [Efficacy of vaccination against hepatitis B in adult with HIV infection].
Kalinowska-Nowak A; Bociaga-Jasik M; Garlicki A; Mach T
Przegl Epidemiol; 2007; 61(2):339-47. PubMed ID: 17956052
[TBL] [Abstract][Full Text] [Related]
13. Comparative efficacy of two dosages of recombinant hepatitis B vaccine in healthy adolescents in India.
Velu V; Nandakumar S; Shanmugam S; Shankar EM; Thangavel S; Kulkarni PS; Thyagarajan SP
Pediatr Infect Dis J; 2007 Nov; 26(11):1038-41. PubMed ID: 17984812
[TBL] [Abstract][Full Text] [Related]
14. Perinatal hepatitis B transmission and vaccination timing in a managed care cohort: assessment of the temporary delay in newborn hepatitis B vaccination due to thimerosal content.
Chang S; Begier EM; Schech SD; Venus P; Shatin D; Braun MM; Ball R
Pediatr Infect Dis J; 2007 Apr; 26(4):329-33. PubMed ID: 17414397
[TBL] [Abstract][Full Text] [Related]
15. Persistence of anti-HBs antibody and immunological memory in children vaccinated with hepatitis B vaccine at birth.
Jafarzadeh A; Montazerifar SJ
J Ayub Med Coll Abbottabad; 2006; 18(4):4-9. PubMed ID: 17591001
[TBL] [Abstract][Full Text] [Related]
16. Hepatitis B immunity in adolescents and necessity for boost vaccination: 23 years after nationwide hepatitis B virus vaccination program in Taiwan.
Lu JJ; Cheng CC; Chou SM; Hor CB; Yang YC; Wang HL
Vaccine; 2009 Nov; 27(47):6613-8. PubMed ID: 19698812
[TBL] [Abstract][Full Text] [Related]
17. Hepatitis B vaccination and the risk of childhood-onset multiple sclerosis.
Mikaeloff Y; Caridade G; Rossier M; Suissa S; Tardieu M
Arch Pediatr Adolesc Med; 2007 Dec; 161(12):1176-82. PubMed ID: 18056563
[TBL] [Abstract][Full Text] [Related]
18. Effect of levamisole supplementation on hepatitis B virus vaccination response in hemodialysis patients.
Sali S; Alavian SM; Hajarizadeh B
Nephrology (Carlton); 2008 Oct; 13(5):376-9. PubMed ID: 18518938
[TBL] [Abstract][Full Text] [Related]
19. [Vaccination scheme in advanced chronic kidney disease].
Barril G; Teruel JL
Nefrologia; 2008; 28 Suppl 3():95-9. PubMed ID: 19018745
[TBL] [Abstract][Full Text] [Related]
20. Vaccination against hepatitis A and B: developments, deployment and delusions.
Zuckerman JN
Curr Opin Infect Dis; 2006 Oct; 19(5):456-9. PubMed ID: 16940869
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
